Activities per year
- 23 results
Search results
-
植物由来化合物の機能性化粧品素材への応用:Ginnalin B の生物活性に関する研究
Kenta Shinzawa (Speaker)
2022/10/16Activity: Talk or presentation › Oral presentation
-
5-C-分岐型デオキシノジリマイシンを基盤としたGAA高親和性シャペロンのデザイン研究
Kenta Shinzawa (Speaker)
2022/10/01Activity: Talk or presentation › Oral presentation
-
In silico解析と親和性測定に基づいたlysosomal acid α-glucosidase (GAA)選択特性を有するイミノ糖のデザイン研究
Kenta Shinzawa (Speaker)
2022/03/28Activity: Talk or presentation › Oral presentation
-
Casuarine誘導体の各種グリコシダーゼに対する阻害活性と構造活性相関
Kenta Shinzawa (Speaker)
2022/03/28Activity: Talk or presentation › Oral presentation
-
植物由来メラニン産生抑制物質の探索と美白効果の検証
Kenta Shinzawa (Speaker)
2022/03/26Activity: Talk or presentation › Oral presentation
-
カエデ由来ginnalin BのNOTCH1を介した皮膚分化促進作用について
Kenta Shinzawa (Speaker)
2020/03/28Activity: Talk or presentation › Oral presentation
-
Discovery of potent glycosidase inhibitors by in situ analysis of a library of hybrid molecules generated via click chemistry.
Kato, A. (Speaker)
2018/07/15 → 2018/07/19Activity: Talk or presentation › Oral presentation
-
NSAIDsは難治性の膵臓がんに対して栄養飢餓選択的に作用する
Kenta Shinzawa (Speaker)
2017/03/25Activity: Talk or presentation › Oral presentation
-
In silico study on the interaction of high affinity ligand calystegine B2 with β-glucocerebrosidase
Kato, A. (Speaker)
2015/12/15 → 2015/12/20Activity: Talk or presentation › Oral presentation
-
Protective effects of dietary 1,5-Anhydro-D-glucitol in diabetes and metabolic syndrome
Kato, A. (Speaker)
2015/12/15 → 2015/12/20Activity: Talk or presentation › Oral presentation
-
Catalytic asymmetric syntheses and biological evaluations of α-1-C-substituted L-iminofuranose derivatives as α-glucosidase inhibitor
Kato, A. (Speaker)
2015/12/15 → 2015/12/20Activity: Talk or presentation › Oral presentation
-
Synthesis and interactions of rhamnose iminosugar mimics with the rhamnose operon, rhamnosidases, and rhamnose isomerase
Kato, A. (Speaker)
2015/12/15 → 2015/12/20Activity: Talk or presentation › Oral presentation
-
Rare sugars as potential inducers of the rhamnose operon: Biotechnology and chemistry in the production of 6-deoxy-hexoses and related monosaccharides
Kato, A. (Speaker)
2015/12/15 → 2015/12/20Activity: Talk or presentation › Oral presentation
-
Fluoro azetidines and difluoro prolines from D-glucose; Inhibition of pancreatic cancer cell growth by a fluoro azetidine
Kato, A. (Speaker)
2014/08/10 → 2014/08/14Activity: Talk or presentation › Oral presentation
-
A nitro sugar based route to branched-chain polyhydroxylated octahydro-1H-indole-4,5,6-triols, as new potential glycosides inhibitors.
Kato, A. (Speaker)
2014/05/28 → 2014/05/30Activity: Talk or presentation › Oral presentation
-
In vitro Iinvestigation of a novel iminosugar, TOP-DNJ.
Kato, A. (Speaker)
2013/10/21 → 2013/10/23Activity: Talk or presentation › Oral presentation
-
Synthesis and biological evaluation of azetidines derivatives from carbohydrates.
Kato, A. (Speaker)
2012/07/22 → 2012/07/27Activity: Talk or presentation › Oral presentation
-
Synthesis of glycosidase inhibitors based on bicyclic azetidines for the treatment of cancer.
Kato, A. (Speaker)
2012/07/22 → 2012/07/27Activity: Talk or presentation › Oral presentation
-
Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors
Kato, A. (Speaker)
2011/11/29 → 2011/12/02Activity: Talk or presentation › Oral presentation
-
Biologically active novel branched pyrrolidines: synthesis of isoDAB and isoLAB.
Kato, A. (Speaker)
2010/12/15 → 2010/12/20Activity: Talk or presentation › Oral presentation
-
Synthesis of potent glycosidase inhibitors including DGJNAc: The first iminosugar to show specific nanomolar inhibiton of α-N-acetylgalactosaminidases.
Kato, A. (Speaker)
2010/12/15 → 2010/12/20Activity: Talk or presentation › Oral presentation
-
Manipulating the glucuronolactone scaffold: Efficient synthesis of potent and specific glycosidase Inhibitors.
Kato, A. (Speaker)
2010/08/01 → 2010/08/06Activity: Talk or presentation › Oral presentation
-
A strategy for the synthesis of all 16 stereoisomers of homonojirimycin (HNJ).
Kato, A. (Speaker)
2010/08/01 → 2010/08/06Activity: Talk or presentation › Oral presentation